RaQualia Pharma's goodwill is $3.6B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
RaQualia Pharma (4579.T) currently reports a goodwill of $3.6B as of June 2026. That compares with $3.8B in the prior-year period — down 5.5% year over year. Use the charts on this page to explore RaQualia Pharma's goodwill history and peer comparisons.
RaQualia Pharma's goodwill decreased from $3.8B to $3.6B — a 5.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
RaQualia Pharma reported $3.6B in goodwill as of June 2026. That compares with $3.8B in the prior-year period — down 5.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current goodwill of $3.6B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for RaQualia Pharma, and consider following 4579.T for alerts when major investors trade the stock.
RaQualia Pharma is classified in the Healthcare sector. On goodwill, it currently shows $3.6B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4579.T with unrelated industries.